Viz.ai Receives First and Only FDA 510(k) Clearance for Subdural Measurements
New AI algorithm enables precise and reliable labeling, visualization and quantification of subdural hemorrhage to make accurate and timely treatment...
Jun 12, 2025
All Resources
Explore our latest resources
New Study Demonstrates AI-Powered Care Coordination Reduces Transfer Time and Improves Outcomes in...
Real-world data highlights how Viz.ai accelerates access to ICH treatment SAN FRANCISCO – June 9, 2025 - Viz.ai, the leader...
Jun 09, 2025
Viz 3D CTA™
Viz 3D CTA delivers AI-enhanced imaging with crystal-clear vessel views by removing bone and venous noise. Empower care teams with interactive...
May 21, 2025
Viz.ai Launches Viz 3D CTA to Deliver Enhanced Imaging and Accelerate Clinical Decision-Making
New feature provides AI-enhanced 3D imaging to improve neurovascular visualization and streamline workflows SAN FRANCISCO – April 30, 2025 -...
Apr 30, 2025
Two New Clinical Studies Demonstrate Accuracy of Viz.ai Algorithm for Intracranial Hemorrhage Volume...
Real-world evidence supports Viz ICH Plus for reliable volume and midline shift estimation SAN FRANCISCO – April 23, 2025 –...
Apr 23, 2025
New Study Demonstrates Significant Impact of AI-Powered Communication in Stroke Patients with Cardiac...
SAN FRANCISCO – March 18, 2025 - Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced...
Mar 18, 2025
Two New Studies Demonstrate Proven Impact of Viz.ai’s Stroke Solution on Patient Outcomes...
Real-world evidence presented at the 2025 International Stroke Conference shows positive impact of AI-powered care coordination on stroke treatment times...
Feb 13, 2025
New Study Highlights Positive Impact of Viz.ai on Enhancing Post-Stroke Patient Care
Clinical study results demonstrate Viz.ai and Medtronic collaboration has helped improve cardiac monitoring utilization, care efficiency, and patient satisfaction with...
Feb 05, 2025
